OL
Oren Livnat HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $65 |
195%
upside
| 3 | +13% |
0
%
| 8 Apr ‘25 6 months ago |
|
|
|
Neutral
Reiterated
| – | – | 2 | – |
–
| 8 Apr ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $50 |
41%
upside
| 2 | +3.9% |
0
%
| 24 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $12.50 |
17%
upside
| 6 | +25% |
0
%
| 19 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $94 |
1%
downside
| 3 | +18% |
0
%
| 17 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $20 |
80%
upside
| 2 | +14% |
0
%
| 13 Mar ‘25 7 months ago |
|
|
|
Buy
Maintained
| $217 |
58%
upside
| 2 | +5% |
0
%
| 10 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $8 |
12%
downside
| 2 | +69% |
0
%
| 7 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $21 |
18%
upside
| 4 | +23% |
0
%
| 4 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $73 |
3%
upside
| 1 | +72% |
0
%
| 26 Feb ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $12 |
281%
upside
| 1 | -8.7% |
0
%
| 18 Feb ‘25 8 months ago |
|